Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 1530 | 351.725 |
09:36 ET | 100 | 351.495 |
09:43 ET | 100 | 352.77 |
09:45 ET | 200 | 354.162 |
09:48 ET | 100 | 353.385 |
09:50 ET | 106 | 353.015 |
09:56 ET | 512 | 351.72 |
09:57 ET | 100 | 351.715 |
10:01 ET | 815 | 351.93 |
10:10 ET | 100 | 353 |
10:15 ET | 403 | 352.99 |
10:17 ET | 1100 | 352.75 |
10:19 ET | 200 | 352.3801 |
10:21 ET | 100 | 353.22 |
10:24 ET | 992 | 352.256205 |
10:26 ET | 214 | 352.77 |
10:32 ET | 300 | 351.49 |
10:33 ET | 3632 | 351.325 |
10:37 ET | 300 | 352.285 |
10:44 ET | 400 | 351.44 |
10:48 ET | 100 | 351.615 |
10:53 ET | 100 | 351.965 |
11:00 ET | 300 | 352.17 |
11:04 ET | 200 | 351.985 |
11:06 ET | 200 | 352.125 |
11:15 ET | 300 | 352.2 |
11:20 ET | 900 | 351.77 |
11:24 ET | 229 | 351.585 |
11:33 ET | 400 | 351.795 |
11:36 ET | 100 | 352.07 |
11:40 ET | 200 | 352.325 |
11:42 ET | 400 | 351.85 |
11:54 ET | 224 | 352.45 |
12:00 ET | 100 | 352.45 |
12:02 ET | 100 | 352.46 |
12:03 ET | 509 | 352.335 |
12:09 ET | 200 | 353.14 |
12:16 ET | 100 | 352.92 |
12:20 ET | 100 | 353.065 |
12:21 ET | 637 | 353.1937 |
12:23 ET | 100 | 353.4 |
12:25 ET | 200 | 353.455 |
12:27 ET | 300 | 353.45 |
12:30 ET | 100 | 353.45 |
12:34 ET | 100 | 353.38 |
12:41 ET | 100 | 353.771 |
12:43 ET | 200 | 354.17 |
12:48 ET | 200 | 353.89 |
12:50 ET | 300 | 353.89 |
01:01 ET | 100 | 353.795 |
01:06 ET | 100 | 353.95 |
01:08 ET | 200 | 353.92 |
01:12 ET | 526 | 353.885 |
01:17 ET | 200 | 354.045 |
01:19 ET | 100 | 354.04 |
01:26 ET | 958 | 353.26 |
01:30 ET | 349 | 353.4062 |
01:35 ET | 200 | 352.86 |
01:42 ET | 100 | 352.47 |
01:46 ET | 100 | 352.465 |
01:51 ET | 100 | 353.1 |
01:55 ET | 100 | 352.58 |
01:57 ET | 100 | 352.575 |
02:00 ET | 300 | 352.68 |
02:13 ET | 200 | 353.055 |
02:15 ET | 100 | 353.04 |
02:18 ET | 1304 | 352.705 |
02:20 ET | 100 | 352.695 |
02:22 ET | 100 | 352.95 |
02:27 ET | 709 | 353.535 |
02:29 ET | 100 | 354.05 |
02:31 ET | 100 | 354.005 |
02:36 ET | 400 | 354 |
02:40 ET | 370 | 354.29 |
02:47 ET | 809 | 354.04 |
02:51 ET | 491 | 353.91 |
02:56 ET | 100 | 354.86 |
03:00 ET | 700 | 354.22 |
03:07 ET | 100 | 354.09 |
03:14 ET | 100 | 353.83 |
03:16 ET | 361 | 354.09 |
03:18 ET | 200 | 354.48 |
03:20 ET | 100 | 354.27 |
03:23 ET | 100 | 354.67 |
03:25 ET | 100 | 354.76 |
03:27 ET | 100 | 354.82 |
03:30 ET | 427 | 354.45 |
03:32 ET | 100 | 354.47 |
03:38 ET | 100 | 354.48 |
03:41 ET | 100 | 354.69 |
03:43 ET | 800 | 354.62 |
03:45 ET | 300 | 354.64 |
03:48 ET | 700 | 354.74 |
03:52 ET | 200 | 355.07 |
03:54 ET | 1400 | 354.645 |
03:56 ET | 1600 | 355.69 |
03:57 ET | 1400 | 355.575 |
03:59 ET | 33907 | 355.93 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 15.8B | 16.4x | +8.22% |
Biomarin Pharmaceutical Inc | 13.2B | 52.4x | --- |
Exact Sciences Corp | 12.6B | -71.2x | --- |
Neurocrine Biosciences Inc | 11.5B | 34.4x | +62.04% |
Medpace Holdings Inc | 10.6B | 32.3x | +35.10% |
Qiagen NV | 9.8B | 136.9x | +12.66% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.8B |
---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 16.4x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | 14.0x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.